drugset / Trial / NCT05220228

Prucalopride and Cognition in Recovered Depression

NCT05220228

Completed 50 enrolled University of Oxford
RandomizedParallel-groupTriple-blindOther

Summary

The current study has two aims: 1. To test the effect of 5-HT4 receptor agonism on cognition (including memory, attention and cognitive control) in individuals with previous history of depression. 2. To explore if prucalopride has an effect on emotional processing biases consistent with its effects on serotonin.

Timeline

Start
2022-01-04
Primary completion
2023-11-13
Completion
2023-11-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Prucalopride Small molecule 2 mg

Indications